Lumida
/NVAX
⌘K
Novavax Inc

Novavax Inc

NVAX
$9.42USD+1.29%+0.12 today

MARKET CAP

1.6B

P/E (TTM)

FWD P/E

DAY RANGE

$9 – $10

52W RANGE

$6
$12

AI Summary

Stalk
StalkMedium

NVAX is consolidating in a neutral to cautious phase within its Stage 2 uptrend, trading between the 9- and 20-day EMAs after a pullback from early-September highs. The long-term trend remains up above the 50- and 200-day SMAs, but short-term momentum has cooled with RSI near 58 and moderate Options Score. Under a speculative strategy, execution favors deferred entries on pullback acceptance into the EMA support zone, avoiding premature buys until clear support is confirmed.

  • Sanofi partnership expands licensed reach toward a $100B-plus vaccine market
  • Q2 product sales up 76% YoY to $19M, driven by Matrix-M adjuvant
  • Q2 revenue plunged to $57M from $239M YoY, showing high fluctuation
Full analysis →

Buying

8

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY13.95 M131.38 M+1.10 M+25.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY3.81 M35.90 M+1.89 M+129.6%0.00%
MM

Millennium Management LLC

Q2 2026

SELL1.79 M16.87 M+-2.08 M-46.5%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY902.65 K8.50 M+790.59 K+832.2%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL764.29 K7.20 M+-788.92 K-43.1%0.01%
RT

Renaissance Technologies LLC

Q2 2026

BUY501.78 K4.73 M+4.40 K+16.8%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY121.63 K991.89 K+60.81 K+142.5%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW82.24 K774.70 K+82.24 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY76.49 K715.92 K+1.29 K+17.7%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY69.81 K657.66 K+17.18 K+53.5%0.00%
FC

Farallon Capital Management LLC

Q1 2026

SELL22.00 K179.08 K+-173.00 K-86.3%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL4.21 K39.67 K+-1.42 K-13.5%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-42.00 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-40.17 K-100.0%0.00%